What are the causes of decreased exhalation in the lungs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Decreased expiration in the lungs is primarily caused by obstructive lung diseases, such as chronic obstructive pulmonary disease (COPD), which can lead to airway collapse and reduced elastic recoil, as well as neuromuscular disorders that weaken respiratory muscles, as supported by the most recent study 1.

Causes of Decreased Expiration

The main causes of decreased expiration in the lungs include:

  • Chronic obstructive pulmonary disease (COPD), which encompasses emphysema and chronic bronchitis
  • Asthma, which causes bronchospasm and inflammation that narrows airways
  • Bronchiectasis and cystic fibrosis, which can lead to airway obstruction
  • Neuromuscular disorders, such as myasthenia gravis or muscular dystrophy, which can weaken respiratory muscles needed for effective exhalation

Pathophysiology

In COPD, destruction of alveolar walls (emphysema) or inflammation and mucus hypersecretion (chronic bronchitis) can lead to airway collapse during exhalation, as explained in 1. The loss of elastic recoil and the increased airway resistance can cause gas trapping and dynamic hyperinflation, leading to decreased expiration.

Treatment

Treatment depends on the underlying cause, but often includes:

  • Bronchodilators, such as albuterol (2 puffs every 4-6 hours as needed) or long-acting agents like tiotropium (18mcg once daily)
  • Anti-inflammatory medications, such as inhaled corticosteroids
  • Oxygen therapy in severe cases These conditions impair exhalation because they either physically obstruct airways or reduce the elastic recoil of lung tissue that normally helps push air out during passive exhalation, as supported by 1 and 1.

From the Research

Causes of Decreased Expiration in Lungs

  • Decreased expiration in lungs can be caused by various factors, including chronic obstructive pulmonary disease (COPD) which is characterized by expiratory flow limitation (EFL) due to progressive airflow obstruction 2.
  • Other factors that may contribute to decreased expiration include acute exacerbations of COPD, which can result in increased airway resistance and inspiratory effort, further leading to dynamic hyperinflation 2.
  • Environmental exposures, infections (viral and bacterial), or bronchial inflammation can also trigger COPD exacerbations, leading to worsening respiratory failure requiring mechanical ventilation (MV) 2, 3.
  • In addition, the exacerbation of other respiratory diseases and non-respiratory diseases (e.g., heart failure, thromboembolism) can also contribute to decreased expiration 3.
  • Asthma is another inflammatory disease characterized by airway obstruction, which can also lead to decreased expiration, especially in patients with overlap between COPD and asthma 4.

Mechanisms of Decreased Expiration

  • The mechanisms that cause expiratory flow limitation (EFL) in COPD are central to understanding the physiopathology of the disease, and include dynamic inflation due to incomplete emptying of the lungs, resulting in auto-positive end-expiratory pressure (PEEP) or PEEPi 2.
  • Airflow obstruction, which is a hallmark of COPD, can also lead to decreased expiration by increasing airway resistance and reducing lung function 5, 6.
  • The use of inhaler therapy, counseling, and pharmacotherapy for smoking cessation, pulmonary rehabilitation, and treatment of comorbidities can help manage COPD and improve lung function, including expiration 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ventilatory strategies in obstructive lung disease.

Seminars in respiratory and critical care medicine, 2014

Research

[Chronic obstructive pulmonary disease and asthma].

Archivos de bronconeumologia, 2010

Research

Chronic Obstructive Pulmonary Disease.

Annals of internal medicine, 2020

Related Questions

What is another potential diagnosis if a patient doesn't meet oxygen saturation requirements?
What are the characteristics of Chronic Obstructive Pulmonary Disease (COPD) presentation?
What are the diagnosis and treatment options for Chronic Obstructive Pulmonary Disease (COPD)?
What is the best course of action for a 68-year-old patient with shortness of breath (SOB), a history of chronic obstructive pulmonary disease (COPD) with emphysema, currently taking inhaled corticosteroid (ICS), long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and using albuterol and ipratropium nebulizers, with recent leukocytosis and impaired renal function, following two COPD exacerbations in the past month?
What is the diagnosis for a 73-year-old patient with a history of Chronic Obstructive Pulmonary Disease (COPD) and lung nodules, who presents with a head injury after a fall, has a normal Computed Tomography (CT) scan, leukocytosis (White Blood Cell count of 11.3), and a Chest X-ray showing limited inspiration, moderate cardiomegaly, and a tortuous thoracic aorta, but no pneumothorax, pleural fluid, or displaced fractures?
Does a history of diverticulosis or Inflammatory Bowel Disease (IBD) increase the risk of colon cancer?
What are the causes of upper Gastrointestinal (GI) bleed?
What is the recommended frequency for monitoring laboratory tests in patients undergoing testosterone (hormone replacement therapy)?
What is the likely diagnosis of a 9mm diameter rounded opacity with dense central calcifications and laminations in the periphery?
Is contact precautions necessary for a patient with Clostridioides difficile (C. diff) nucleic acid amplification test (NAAT) positive result but toxin negative?
What is a suitable selective serotonin reuptake inhibitor (SSRI) for a 30-year-old postpartum woman with depression and Crohn's disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.